BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gong SS, Fan YH, Han QQ, Lv B, Xu Y. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2240-2250 [PMID: 31143074 DOI: 10.3748/wjg.v25.i18.2240]
URL: https://www.wjgnet.com/1948-5182/full/v25/i18/2240.htm
Number Citing Articles
1
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet. A Practical Guide for Faecal Calprotectin Measurement: Myths and RealitiesJournal of Crohn's and Colitis 2021; 15(1): 152 doi: 10.1093/ecco-jcc/jjaa093
2
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
3
Scott D. Lee, Jessica R. Allegretti, Flavio Steinwurz, Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, Krisztina B. Gecse. Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscoreBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-022-02508-2
4
Vincenzo Craviotto, Federica Furfaro, Laura Loy, Alessandra Zilli, Laurent Peyrin-Biroulet, Gionata Fiorino, Silvio Danese, Mariangela Allocca. Viral infections in inflammatory bowel disease: Tips and tricks for correct managementWorld Journal of Gastroenterology 2021; 27(27): 4276-4297 doi: 10.3748/wjg.v27.i27.4276
5
S. A. Tsvetikova, E. E. Kruglov, L. G. Danilov, D. S. Zilov, Yu. V. Myakisheva, M. A. Makarova, L. A. Kaftyreva, E. I. Koshel. Composition and Pathogenic Potential of Mucosal Microbiota in Ulcerative ColitisRussian Journal of Bioorganic Chemistry 2024; 50(2): 582 doi: 10.1134/S1068162024110463
6
Anand Kumar, Tatiana Teslova, Erin Taub, Joshua D. Miller, Dana J. Lukin. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious ComplicationsDigestive Diseases and Sciences 2021; 66(6): 2005 doi: 10.1007/s10620-020-06439-4
7
Cátia Arieira, Francisca Dias de Castro, Tiago Cúrdia Gonçalves, Maria J. Moreira, José Cotter. Combination therapy in inflammatory bowel disease patients: do we need to maximize the dose of azathioprine?Scandinavian Journal of Gastroenterology 2020; 55(8): 920 doi: 10.1080/00365521.2020.1792543
8
Maede Ghanaeipour, Nima Behnaminia, Erfan Khadem, Amirhossein Nafari. The Risk of Opportunistic Infections in Patients with Inflammatory Bowel DiseaseThe International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666220124111511
9
Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysisWorld Journal of Pediatrics 2022; 18(1): 27 doi: 10.1007/s12519-021-00486-1
10
Kathryn Gazelakis, Isabel Chu, Catherine Martin, Miles P. Sparrow. Infections in inflammatory bowel disease patients on immunomodulator and biologic therapy are not associated with high serum drug levelsInternal Medicine Journal 2024; 54(1): 139 doi: 10.1111/imj.16105
11
Trusha Patel, Andrew B. Grossman. Updates in Healthcare Maintenance and Monitoring of Children with Inflammatory Bowel Disease in the Era of Biologic TherapiesCurrent Treatment Options in Pediatrics 2019; 5(4): 466 doi: 10.1007/s40746-019-00181-4
12
Luigi Marongiu, Sascha Venturelli, Heike Allgayer. Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-AnalysisCancers 2022; 14(20): 5085 doi: 10.3390/cancers14205085
13
Elisa Morales-Marroquin, Luyu Xie, Madhuri Uppuluri, Jaime P. Almandoz, Nestor de la Cruz-Muñoz, Sarah E. Messiah. Immunosuppression and Clostridioides (Clostridium) difficile Infection Risk in Metabolic and Bariatric Surgery PatientsJournal of the American College of Surgeons 2021; 233(2): 223 doi: 10.1016/j.jamcollsurg.2021.04.028